Shared Decision Making Tools for Kidney Transplantation

Recruiting at 1 trial location

Overseen By Miko Yu, MA

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Columbia University

Disqualifiers: Non-English/Spanish, Under 18

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

37 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to increase shared decision-making between dialysis providers and patients in order to increase patients' probability of transplantation and to reduce socioeconomic/racial disparities in access to kidney transplantation. Participants will receive educational material over the course of 4-6 months about different aspects of the kidney transplant and waitlisting process.

Who Is on the Research Team?

Sumit Mohan, MD, MPH

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for adults on hemodialysis at select clinics in New York and Cleveland who are either on a kidney transplant waitlist or undergoing evaluation at CU/NYPH Transplant Center or the Cleveland Clinic. Participants must speak English or Spanish.

Inclusion Criteria

I am undergoing hemodialysis at a specified clinic.

You are currently on a waitlist or being evaluated for a transplant at Columbia University/New York Presbyterian Hospital (CU/NYPH) or at the Cleveland Clinic (CC).

Exclusion Criteria

I am under 18 years old.

I speak a language other than English or Spanish.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Educational Intervention

Participants receive educational materials and personalized informational letters about the kidney transplantation and waitlisting process

4-6 months

Quarterly letters

Follow-up

Participants are monitored for changes in knowledge and preferences regarding kidney transplantation

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Patient letters
• Provider educational materials

Trial Overview The study aims to improve kidney transplantation rates by using educational materials to enhance decision-making between patients and providers over a period of 6-12 months, focusing also on reducing disparities in access.

How Is the Trial Designed?

Group I: Providers Experimental Treatment 1 Intervention

Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.

Group II: Patients Experimental Treatment 1 Intervention

Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process.

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials

1,529

Recruited

2,832,000+

National Kidney Foundation

Collaborator

Trials

33

Recruited

85,800+

Kidney Transplant Collaborative

Collaborator

Trials

1

Recruited

450+

National Kidney Foundation, United States

Collaborator